Describe the etiology of hematologic malignancies in HIV-infected patients. |
|
|
|
|
|
|
Analyze refined treatment options for HIV-infected patients – revisiting bone marrow transplant and CART cell therapy – to determine the best course of treatment for these patients. |
|
|
|
|
|
|
Recognize the importance of utilizing the appropriate sequence in the treatment of HIV-associated hematologic malignancies. |
|
|
|
|
|
|